Financial Snapshot

Revenue
$361.4K
TTM
Gross Margin
30.01%
TTM
Net Earnings
-$562.1K
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
61.83%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$1.566M
Q3 2024
Cash
Q3 2024
P/E
-56.57
Nov 29, 2024 EST
Free Cash Flow

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2024 2023 2022 2021 2020
Revenue $686.00 $15.10K $548.6K $211.6K $0.00
YoY Change -95.46% -97.25% 159.31%

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2024 2023 2022 2021 2020
Revenue $686.00 $15.10K $548.6K $211.6K $0.00
Cost Of Revenue $1.092K $6.650K $439.3K $166.0K $0.00
Gross Profit -$406.00 $8.450K $109.2K $45.59K $0.00
Gross Profit Margin -59.18% 55.96% 19.91% 21.55%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2024 2023 2022 2021 2020
Selling, General & Admin $5.518K $384.6K $543.4K $36.89K $0.00
YoY Change -98.57% -29.22% 1372.95%
% of Gross Profit 4551.36% 497.45% 80.92%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $144.8K $384.6K $543.4K $36.89K $0.00
YoY Change -62.34% -29.22% 1372.95%
Operating Profit -$145.2K -$376.1K -$434.1K $8.700K $0.00
YoY Change -61.39% -13.36% -5090.11%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2024 2023 2022 2021 2020
Interest Expense $10.92K -$9.740K -$8.850K
YoY Change -212.15% 10.06%
% of Operating Profit
Other Income/Expense, Net -$10.91K -$9.737K -$8.844K
YoY Change 12.09% 10.1%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2024 2023 2022 2021 2020
Pretax Income -$156.2K -$385.9K -$443.0K $8.700K $0.00
YoY Change -59.53% -12.89% -5191.72%
Income Tax $0.00 $0.00 $0.00 $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$156.2K -$385.9K -$443.0K $8.700K $0.00
YoY Change -59.53% -12.89% -5191.72%
Net Earnings / Revenue -22762.83% -2555.5% -80.75% 4.11%
Basic Earnings Per Share $0.00 $0.00 -$0.01
Diluted Earnings Per Share $0.00 $0.00 -$590.10 $17.02 $0.00

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2024 2023 2022 2021 2020
Cash & Short-Term Investments $3.200K $13.49K $111.4K $72.77K $0.00
YoY Change -76.28% -87.89% 53.09%
Cash & Equivalents $3.200K $13.49K $111.4K $72.77K $0.00
Short-Term Investments
Other Short-Term Assets $0.00 $4.420K
YoY Change -100.0%
Inventory $610.00 $1.700K
Prepaid Expenses
Receivables $0.00 $30.00 $5.620K $1.590K $0.00
Other Receivables $0.00 $0.00 $0.00 $0.00 $0.00
Total Short-Term Assets $3.810K $15.22K $121.4K $74.36K $0.00
YoY Change -74.97% -87.47% 63.3%
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00 $0.00 $0.00
YoY Change
Total Assets $3.810K $15.22K $121.4K $74.36K $0.00
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $577.1K $540.5K $281.2K $1.780K $0.00
YoY Change 6.78% 92.24% 15694.94%
Deferred Revenue
YoY Change
Short-Term Debt $133.8K $133.6K $133.6K $0.00 $0.00
YoY Change 0.21% 0.0%
Long-Term Debt Due $84.28K $84.08K
YoY Change 0.24%
Total Short-Term Liabilities $989.8K $837.1K $479.1K $65.67K $0.00
YoY Change 18.24% 74.73% 629.51%
Long-Term Debt $0.00 $0.00 $76.58K $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $76.58K $0.00 $0.00
YoY Change -100.0%
Total Liabilities $989.8K $837.1K $555.7K $65.67K $0.00
YoY Change 18.24% 50.65% 746.12%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2024 2023 2022 2021 2020
Basic Shares Outstanding 831.3M shares 831.3M shares 831.3M shares
Diluted Shares Outstanding 831.3M shares 831.3M shares 831.3M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $31.8 Million

About DH ENCHANTMENT, INC.

DH Enchantment, Inc. is a holding company which has no operation of its own. The company employs 1 full-time employees The company went IPO on 2004-10-29. The firm conducts its operations through its Hong Kong subsidiary, Ho Shun Yi Limited (HSY). HSY is engaged primarily in the sale and distribution of COVID-19 rapid antigen tester sets. HSY is one of the authorized commercial distributors of the INDICAID COVID-19 Rapid Antigen Test in the Hong Kong market. The INDICAID COVID-19 Rapid Antigen Test is developed and manufactured in Hong Kong. The INDICAID product can provide a COVID-19 testing result in approximately 20 minutes. HSY’s main customers are distributors of personal hygiene products into the market.

Industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries Peers: